<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-11-18">November 18, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sibylle</forename><surname>Junge</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Clinic for Paediatric Pulmonology, Allergology and Neonatology</orgName>
								<address>
									<settlement>Hannover, Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dennis</forename><surname>Go</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Martijn</forename><surname>2☯</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Biostatistics and Clinical Research</orgName>
								<orgName type="institution">University Hospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><surname>Den Reijer</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medical Microbiology and Infectious Diseases</orgName>
								<orgName type="institution">Erasmus Medical Center Rotterdam</orgName>
								<address>
									<addrLine>The Netherlands</addrLine>
									<settlement>Rotterdam</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ba</forename><surname>¨rbel Wiedemann</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Medical Informatics and Biometrics</orgName>
								<orgName type="institution">Technical University Dresden</orgName>
								<address>
									<settlement>Dresden, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Burkhard</forename><surname>Tu ¨mmler</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Clinic for Paediatric Pulmonology, Allergology and Neonatology</orgName>
								<orgName type="laboratory">Clinical Research Group</orgName>
								<orgName type="institution">Medizinische Hochschule Hannover</orgName>
								<address>
									<settlement>Hannover, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Helmut</forename><surname>Ellemunter</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">CF-Center Innsbruck</orgName>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Department of Child and Adolescent Health</orgName>
								<orgName type="institution">Medical University of Innsbruck</orgName>
								<address>
									<settlement>Innsbruck</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angelika</forename><surname>Du ¨bbers</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">University Hospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Ku ¨ster</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">Clemenshospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manfred</forename><surname>Ballmann</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Ruhr University</orgName>
								<orgName type="institution" key="instit2">Paediatric Clinic at St Josef Hospital</orgName>
								<address>
									<settlement>Bochum, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cordula</forename><surname>Koerner-Rettberg</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution" key="instit1">Ruhr University</orgName>
								<orgName type="institution" key="instit2">Paediatric Clinic at St Josef Hospital</orgName>
								<address>
									<settlement>Bochum, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jo</forename><surname>¨rg Große-Onnebrink</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">University Hospital Essen</orgName>
								<address>
									<settlement>Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eberhardt</forename><surname>Heuer</surname></persName>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">12 CF Center</orgName>
								<orgName type="department" key="dep2">Department of Paediatrics</orgName>
								<orgName type="institution">Paediatricians &quot;Kindera ¨rztliche Ambulanz&quot;</orgName>
								<address>
									<settlement>Hamburg, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfgang</forename><surname>Sextro</surname></persName>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">12 CF Center</orgName>
								<orgName type="department" key="dep2">Department of Paediatrics</orgName>
								<orgName type="institution">Paediatricians &quot;Kindera ¨rztliche Ambulanz&quot;</orgName>
								<address>
									<settlement>Hamburg, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="institution">Jena University Hospital</orgName>
								<address>
									<settlement>Jena, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jochen</forename><forename type="middle">G</forename><surname>Mainz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jutta</forename><surname>Hammermann</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">University Clinics Dresden</orgName>
								<address>
									<settlement>Dresden, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joachim</forename><surname>Riethmu ¨ller 14</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Department of Pediatrics</orgName>
								<address>
									<addrLine>University Clinics Tu ¨bingen, Tu ¨bingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ute</forename><surname>Graepler-Mainka</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Department of Pediatrics</orgName>
								<address>
									<addrLine>University Clinics Tu ¨bingen, Tu ¨bingen</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Doris</forename><surname>Staab</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Paediatric Pulmonology and Immunology</orgName>
								<orgName type="institution">Charite ´Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bettina</forename><surname>Wollschla ¨ger</surname></persName>
							<affiliation key="aff16">
								<orgName type="institution">University Hospital Halle</orgName>
								<address>
									<settlement>Halle, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ru</forename><surname>¨diger Szczepanski</surname></persName>
							<affiliation key="aff17">
								<orgName type="institution">Children&apos;s Hospital Osnabru ¨ck</orgName>
								<address>
									<addrLine>Osnabru ¨ck</addrLine>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antje</forename><surname>Schuster</surname></persName>
							<affiliation key="aff18">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">University of Du ¨sseldorf</orgName>
								<address>
									<addrLine>Du ¨sseldorf, 19 Park Scho ¨nefeld Clinics, 20 Ruhrlandklinik</addrLine>
									<settlement>Germany, Kassel, Germany, Essen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Friedrich-Karl</forename><surname>Tegtmeyer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sivagurunathan</forename><surname>Sutharsan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alexandra</forename><surname>Wald</surname></persName>
							<affiliation key="aff19">
								<orgName type="institution">University Clinics Leipzig</orgName>
								<address>
									<settlement>Leipzig, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jerzy-Roch</forename><surname>Nofer</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Center for Laboratory Medicine</orgName>
								<orgName type="institution">University Hospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Willem</forename><surname>Van Wamel</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medical Microbiology and Infectious Diseases</orgName>
								<orgName type="institution">Erasmus Medical Center Rotterdam</orgName>
								<address>
									<addrLine>The Netherlands</addrLine>
									<settlement>Rotterdam</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karsten</forename><surname>Becker</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Institute of Medical Microbiology</orgName>
								<orgName type="institution">University Hospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Peters</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Institute of Medical Microbiology</orgName>
								<orgName type="institution">University Hospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Barbara</forename><forename type="middle">C</forename><surname>Kahl</surname></persName>
							<email>kahl@uni-muenster.de</email>
							<affiliation key="aff21">
								<orgName type="department">Institute of Medical Microbiology</orgName>
								<orgName type="institution">University Hospital Mu ¨nster</orgName>
								<address>
									<addrLine>Mu ¨nster</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-11-18">November 18, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">624E76052ACFCD5711DBC5FF0D72FF26</idno>
					<idno type="DOI">10.1371/journal.pone.0166220</idno>
					<note type="submission">Received: June 25, 2016 Accepted: October 25, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Staphylococcus aureus is an important pathogen in cystic fibrosis (CF).</s><s>However, it is not clear which factors are associated with worse lung function in patients with persistent S. aureus airway cultures.</s><s>Our main hypothesis was that patients with high S. aureus density in their respiratory specimens would more likely experience worsening of their lung disease than patients with low bacterial loads.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>Therefore, we conducted an observational prospective longitudinal multi-center study and assessed the association between lung function and S. aureus bacterial density in PLOS ONE |</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Cystic fibrosis (CF) patients suffer from recurrent bacterial airway infections, which often lead to respiratory insufficiency and reduced life expectancy <ref type="bibr" target="#b0">[1]</ref>.</s><s>Staphylococcus aureus is one of the most frequently isolated pathogens from the airways of these patients <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr">[4]</ref>.</s><s>Recent studies have shown the importance of S. aureus in young children with CF by way of eliciting an increased inflammatory response measured in broncho-alveolar lavages <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref>.</s><s>Thirty percent of the general population are persistent nasal carriers of S. aureus and this percentage is even higher in CF patients <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s>Nasal carriers have been shown to have a higher risk for S. aureus infections, but a lower rate of lethal infections <ref type="bibr" target="#b12">[13]</ref>.</s><s>It is often difficult to decide whether culturing S. aureus in respiratory specimens from CF patients is merely caused by colonization or whether this is also associated with worsening lung disease requiring antibiotic treatment.</s><s>To support clinical decision, interleukin-6 levels in blood, which have been shown to increase in CF patients during airway inflammation <ref type="bibr" target="#b13">[14]</ref>, may serve as a potential marker for severity of inflammation.</s></p><p><s>In the present study, our goal was to determine risk factors associated with worse lung function in CF patients older than six years, who had been persistently colonized by S. aureus.</s><s>We thus conducted a prospective observational longitudinal multi-center study (ClinicalTrials.</s><s>gov: NCT00669760).</s><s>We hypothesized that patients with high bacterial loads of S. aureus in airway specimens were more likely to experience worse lung function compared to patients with lower bacterial loads.</s><s>Secondary objectives were the association between lung function and S. aureus nasal carriage in CF patients, the role of blood IL-6 levels and IgG levels against 44 S. aureus virulence factors, presence of small colony variants (SCVs) of S. aureus and coinfection with other CF-related pathogens such as Stenotrophomonas maltophilia, methicillinresistant S. aureus (MRSA), Aspergillus fumigatus, Achromobacter xylosoxidans and Mycobacterium abscessus on lung function.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p><s>We conducted an observational prospective multicenter study to evaluate risk factors for worse lung function in patients with persistent S. aureus airway cultures older than 6 years.</s><s>The treating physicians recruited CF patients for the study by using the following definitions for persistence from the medical records: 1. Patients presented with at least 2 positive cultures 6 months apart within one year before recruitment, or 2. half of the respiratory samples the year before recruitment were S. aureus positiv.</s><s>The first patient was recruited in June 2008, the last patient finished the observation period in February 2010.</s><s>At each visit throat or sputum cultures were obtained and sent to the central study laboratory located in Mu ¨nster, Germany.</s><s>On the basis of a study investigating chronic bronchitis patients <ref type="bibr" target="#b14">[15]</ref>, we hypothesized that CF-patients with high loads (in sputa !1x10 6 CFU/ml; in throat cultures semi-quantitative score !3) of S. aureus in their airway specimens are more likely to experience worsening of lung disease due to S. aureus than patients with low bacterial loads.</s><s>To rule out an impact of P. aeruginosa or Burkholderia cepacia complex (BCC) on lung function, patients with cultures of these two pathogens were excluded.</s><s>We defined exacerbation by evaluating clinical symptoms established by Fuchs et al. for the assessment of exacerbation <ref type="bibr" target="#b15">[16]</ref>.</s><s>If a patient met at least four out of 11 evaluated symptoms, the clinical status was determined as exacerbation.</s></p><p><s>Secondary objectives included the association between nasal S. aureus carriage, the level of IL-6, the presence of S. aureus small colony variants (SCVs) and the co-culture of other important CF pathogens such as S. maltophilia, A. xylosoxidans, A. fumigatus and M. abscessus and the risk for exacerbation or worse lung function.</s></p><p><s>Inclusion criteria.</s><s>CF Individuals older than six years were included with persistent S. aureus airway cultures one year before recruitment.</s></p><p><s>Enrollment and follow-up.</s><s>Patients identified as persistently colonized by S. aureus as defined by our inclusion criteria were enrolled in this study by their attending CF specialists.</s><s>If P. aeruginosa or BCC were cultured for more than 6 months during the study period, patients were excluded from further analysis.</s><s>Patients were followed for a period of 21 months with regular visits (usually every 3 months).</s><s>Sputum samples were spontaneously produced.</s><s>There were no requirements for induced sputum cultures.</s><s>Blood samples were taken from patients once yearly and/or at exacerbations.</s><s>An ethical statement was obtained at the main study center with the central laboratory in Mu ¨nster, Germany (2007-496-f-S).</s><s>Other ethical statements have been obtained from the Universita ¨tsklinikum Tu ¨bingen 450/2008B02, Martin-Luther-Universita ¨t Halle Wittenberg hm/bu, A ¨rztekammer Hamburg MC039/09 and the Universita ¨tsklinikum Dresden.</s><s>All other ethic committees at the Ruhr Universita ¨t Bochum, Universita ¨tsklinik Essen, Medizinische Hochschule Hannover, Universita ¨tsklinikum Jena, Charite Úniversita ¨tsmedizin Berlin, Campus Virchow Klinikum, Kinderkrankenhaus Osnabru ¨ck, Universita ¨tsklinik Innsbruck, Universita ¨tsklinik Du ¨sseldorf, Park Scho ¨nefeld Klinik Kassel and the Universita ¨tsklinikum Leipzig waived their approval.</s><s>Written informed consent was obtained from all patients and parents, if patients were younger than 18 years.</s><s>Clinical trial registered with www.clinicaltrials.gov</s><s>(NCT00669760).</s></p><p><s>Investigated Fuchs criteria and clinical report forms (CRFs) <ref type="bibr" target="#b15">[16]</ref> At every visit patients performed lung function tests assessed as forced expiratory volume in 1 second (FEV 1 ).</s><s>Other recorded clinical parameters included the presence of fatigue, malaise or lethargy, sinus discharge, cough and hemoptysis as well as sputum volume or color.</s><s>These data were documented by the treating physicians in CRFs, together with CFTR genotype, pancreas sufficiency/insufficiency, physical and radiographic findings on examination of the chest, body mass index and antibiotic therapy.</s><s>The CRFs were sent together with the respiratory specimens to the central laboratory in Mu ¨nster, Germany.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microbiology</head><p><s>All airway and blood samples obtained from patients were sent to the central study laboratory (Medical Microbiology, Mu ¨nster, Germany) within 24 hours and were cultured according to standard procedures for CF airway cultures <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s>All samples were streaked on Columbia sheep blood agar (Becton Dickinson, Heidelberg, Germany), MacConkey agar for Gram-negative bacteria (Becton Dickinson, Heidelberg, Germany), SAID chromogenic agar for S. aureus, (bioMerieux, Nu ¨rtingen, Germany), all incubated for 48h at 37˚C; on chocolate agar (Mast Diagnostica, Reinfeld, Germany) for Haemophilus influenzae, incubated for 48h at 37˚C with 5% CO 2 ; on BCSA agar (bioMerieux, Nu ¨rtingen, Germany) for Burkholderia cepacia complex, incubated at 30˚C for 10 days, and on Kimmig agar for fungi.</s><s>In case of mucoid consistency, sputa were incubated with sputasol (dithiotreitol, Oxoid, Wesel, Germany) for 30 min at 37˚C and homogenized by vortexing and vigorous pipetting before further processing.</s><s>Quantitative cultures of sputa were performed by serial dilution of 500μl of sputum in 4.5ml 0.85% NaCl according to standard procedures.</s><s>Semi-quantitative analysis was performed for throat and nasal cultures and for sputa of less than 500μl sputum.</s><s>A score of 1 was assigned to single S. aureus colonies on the primary agar plate, a score of 2 to medium density and a score of 3 to highly dense numbers of S. aureus colonies on the primary agar plate, respectively.</s><s>SCVs were identified by sub-culturing isolates of interest from Columbia blood and SAID agar on Columbia blood agar (incubated at 37˚C) and on Schaedler agar (incubated at 37˚C with 5% CO 2 ) for 24h <ref type="bibr" target="#b18">[19]</ref>.</s><s>All isolates, which displayed small colony size on Columbia blood and normal size on Schaedler agar were identified as SCVs, which was further confirmed by a positive catalase and positive Pasteurex Staph Plus test (BIO-RAD, Mu ¨nchen, Germany).</s><s>In case of negative results, isolates were identified by 16S-RNA sequencing.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurements of anti-staphylococcal antibodies</head><p><s>The levels of IgG antibodies against 44 staphylococcal antigens in serum samples of CF patients and 53 healthy nasal carriers, who consisted of volunteers of the Institute of Medical Microbiology and medical students, were measured using a bead-based flow cytometry technique (xMAP 1 ; Luminex Corporation) as previously described <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s>All examined antigens are given in S1 Supporting Material.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-6 measurements</head><p><s>IL-6 levels in sera were determined by ELISA (R&amp;D, Wiesbaden, Germany) according to manufacturer instructions and S1 Supporting Material.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Patient data were collected longitudinally.</s><s>The baseline patient characteristics were analyzed by standard descriptive statistics.</s><s>Categorical variables were described by absolute and relative frequencies.</s><s>Continuous variables were described by median and range.</s><s>The following variables were computed:</s></p><p><s>Lung function (FEV 1 % predicted) was determined on the basis of Quanjer et al. <ref type="bibr" target="#b21">[22]</ref>.</s><s>SCV status (never/ever) of the patients was positive (ever), if SCVs were detected in specimens at any visit.</s><s>Carrier status was deemed positive, if in at least at 50% of visits S. aureus nasal carriage was detected.</s><s>Exacerbation status (never/ever) was calculated using the symptoms defined by Fuchs <ref type="bibr" target="#b15">[16]</ref>.</s><s>A visit with Fuchs score in excess of 4 was defined as an exacerbation visit.</s><s>Patients exhibiting at least one exacerbation visit were assigned to the exacerbation ever group.</s><s>S. aureus density [sputa: high (&lt;10 6 CFU/ml and low &lt;10 6 CFU/ml according to Mensa and Trilla for patients with chronic bronchitis; <ref type="bibr" target="#b14">[15]</ref> nasal and throat swabs: high &gt;/ = +++; low + or ++)] was determined based on quantitative and semi-quantitative data per visit.</s><s>Patients' co-infection status (never/ever) with MRSA, S. maltophilia and A. fumigatus was determined by compiling information from all visits.</s></p><p><s>Outcome parameters of interest were bacterial density (high/low) in different specimens, lung function (FEV 1 % predicted) and interleukin-6 (IL-6) levels.</s></p><p><s>Cross-sectional analyses, e.g. at baseline, were performed using Mann-Whitney-U tests from continuous variables and Chi-Squared tests, or Fisher's exact tests for categorical variables.</s><s>Longitudinal analyses were performed to assess the effect of different explanatory variables on the outcome parameters.</s><s>To model patient progress over time we used generalized linear mixed models (GLMM).</s><s>Bacterial density was modeled by a binary distribution.</s><s>FEV 1 % proved to be normally distributed.</s><s>IL-6 levels were skewed to the right and a log-normal distribution was used to fit the data.</s><s>The canonical link function was used.</s><s>For all models, a random effect for the individual progress of each patient over the study time (days from first visit) was included using sp(pow) as covariance structure.</s><s>All models were age and gender adjusted, if not otherwise specified.</s><s>Studentized residual plots were used to examine model requirements.</s></p><p><s>To analyze the functional dependency of FEV 1 % on IL-6 levels a polynomial model was used: FEV1 = β1 × [IL6] β2 .</s><s>The model coefficients were fitted using only baseline measurement using procnlin in SAS.</s></p><p><s>Each variable for the specific IgG measurements was tested for normal distribution using histogram plots, Q-Q plots and the Kolmogorov-Smirnov test.</s><s>For the comparison of the IgG levels between patients and healthy controls the multiple testing problem was controlled by Bonferroni correction.</s><s>Age and gender adjusted GLMM were used to analyse specific IgGresponses according to carrier status (yes/no), density (high/low) in sputa, SCV (ever/never) including a random effect for repeated measurement.</s><s>q-values were Bonferroni-Holm adjusted p-values to control the FDR on the multiple significance level of 5%.</s><s>IgG-levels were modelled as continuous factors.</s><s>Odds ratios (OR) were interpreted as a factor, by which the risk for carriage/high-density/SCV was changed per 100 units in antigen levels.</s><s>For an association of IL-6 and FEV 1 % predicted with IgG-levels, estimates were interpreted as mean change in IL-6 per 1 unit in IgG-levels.</s></p><p><s>The local significance level for all performed tests was α = 0.05.</s><s>95%-confidence intervals are given, where appropriate.</s><s>Statistical tests are performed exploratory and can be interpreted as hypothesis generating.</s><s>Statistical analysis was performed using SPSS (v.</s><s>22, IBM) and SAS (v.</s><s>9.4, SAS Institute, Cary, NC).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Demographics and statistics</head><p><s>A total of 195 patients were recruited from 16 German centers and one CF center in Austria, which take care of 1980 CF patients.</s><s>Thirteen of 195 patients r were excluded due to the chronic culture (&gt; 6 months) of P. aeruginosa (n = 12) or BCC (n = 1) during the study period.</s><s>Cystic fibrosis transmembrane regulator (CFTR) genotypes were reported for 173 of 195 patients, see Table <ref type="table" target="#tab_0">1</ref>.</s><s>Patients with non-p.Phe508del CFTR genotypes (n = 48; 27.7%) were overrepresented compared to the German CF patient population (Table <ref type="table" target="#tab_0">1</ref>, p&lt;0.0001).</s><s>The median age of patients was 16 years (range 5.8 y-42 y).</s><s>A preponderance of male to female subjects compared to the gender ratio of the German CF registry was reported (Table <ref type="table" target="#tab_0">1</ref>, p&lt;0.001).</s></p><p><s>The mean number of all visits was seven (range 1-18).</s><s>Clinical data of patients at baseline are shown and compared with national data concerning German CF patients in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Lung function decline was -1.2717 FEV 1 % predicted per years of age calculated for the study group at the first visit (CI -1.6676/-0.7235;</s><s>p&lt;0.0001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Age-bacterial density association</head><p><s>For 98 patients at least one sputum (n = 446, range 1-14) was available for analysis, while for 97 patients only throat cultures (n = 663, range 1-11) were available.</s><s>The age of patients at the time of the first positive S. aureus sputum culture was significantly associated with S. aureus density in sputa, indicating that older patients had significantly higher bacterial loads in sputa compared to younger patients (p = 0.018).</s><s>Patients with low bacterial density in sputa were on average 19.2 years of age, while patients with high bacterial loads were 22.2 years of age, respectively.</s><s>There was no association between age and S. aureus density for patients with only throat (p = 0.7016) or nasal cultures (p = 0.411).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bacterial density and lung function</head><p><s>Bacterial density according to specimens is shown in Table <ref type="table" target="#tab_1">2</ref>.</s><s>No significant association, adjusted for age and sex, was reported between S. aureus density and FEV 1 % predicted in neither patients with sputum (p = 0.5151) nor throat cultures (p = 0.185).</s><s>There was also no Age, FEV1, BMI and exacerbation numbers are reported as median (range), respectively.</s><s>Exocrine pancreatic sufficiency and genotype are reported as absolute frequencies (relative frequencies).</s><s>We did not exclude one patient, who was 5.8 years at the first visit, but was 6.1 years at the second visit with seven reported visits throughout the study period.</s><s>association of FEV 1 % predicted with BMI-quantiles for both groups (p = 0.4352; p = 0.1007) neither at baseline nor during the study period.</s></p><p><s>However, bacterial density in throat specimens was significantly associated with annual lung function decline.</s><s>Patients with high density lost 1.428% FEV 1 per year compared to patients with low density, Fig 1 (0.8626%FEV 1 ; p&lt;0.001 of the interaction of age and density).</s><s>We could not observe similar associations with respect to bacterial density in sputum cultures and lung function decline (data not shown).</s></p><p><s>The Figs 1-5 show observed FEV 1 % predicted measurements over study time (days from first visit).</s><s>Lines represent the LOESS-fit including 95% confidence intervals of the predicted values of the generalized linear mixed model.</s></p><p><s>There was a strong association between FEV 1 % predicted and bacterial density and cumulative clinical symptoms according to Fuchs criteria <ref type="bibr" target="#b15">[16]</ref> for patients who expectorated sputa (95 patients, max. 9 visits; p = 0.0661, S1 Fig) <ref type="figure">,</ref> but not for patients with throat cultures (167 patients, max. 9 visits).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients with exacerbations have worse lung function</head><p><s>Sixty of 195 patients (31%; 55% male) experienced exacerbations with a mean number of 0.384 exacerbations per patient (range 0, 4).</s><s>The age distribution of patients with and without exacerbation did not differ significantly (assessed at baseline, p = 0.5182, S1 Table <ref type="table">)</ref>.</s><s>Using a longitudinal multivariable model adjusted for age and sex our data showed that patients with exacerbations have worse lung function of 5.40% FEV 1 % predicted (95%CI 1.50 to 9.30 FEV 1 %) less compared to patients without exacerbations (p = 0.0068, <ref type="bibr">Fig 2)</ref>.</s><s>Patients with exacerbations have a lung function decline per year of age of 1.22% FEV 1 % predicted (95%CI 0.94 to 1.50 FEV 1 %) compared to 0.88% FEV 1 % (95%CI 0.64 to 1.12 FEV 1 %) predicted in patients without exacerbations (p = 0.0018).</s><s>Patients with exacerbations received more antibiotics than patients without exacerbations (p = 0.037, OR = 1.175).</s><s>For patients with exacerbations antibiotic treatment was reported at five visits (mean 4.3), while for patients without exacerbations at three visits (mean 3.43, p = 0.021), respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients with S. aureus nasal carriage</head><p><s>Since persistent nasal S. aureus carriers differ from non-carriers in terms of severe S. aureus infections <ref type="bibr" target="#b9">[10]</ref>, we determined the nasal carriage status of our study patients to analyze its impact on CF lung disease.</s><s>CF patients with persistent nasal carriage (n = 122, 62.6%) were more likely male patients compared to patients without persistent nasal carriage (p = 0.00075, S1 Table <ref type="table">)</ref> and had significantly more nasal cultures with high bacterial loads (p = 0.0255).</s><s>S. aureus nasal carriers had better lung function throughout the study compared to non-carriers with a difference of 5.758 FEV 1 % predicted (95%CI 1.84 to 9.68; p = 0.0042; Fig <ref type="figure" target="#fig_3">3</ref>).</s><s>It is noteworthy that female nasal carriers experienced better lung function throughout the study period compared to male carriers (p = 0.0064, age-adjusted).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients with S. aureus SCVs</head><p><s>To determine the impact of S. aureus SCVs on lung disease data were analyzed in relation to the culture of SCVs in airway specimens, which were cultured from 84 patients (43%) at least once.</s><s>Patients with SCVs were significantly older (p = 0.0066), had lower FEV 1 % predicted at baseline (p = 0.0133) and during the study period (p = 0.0337, age and gender adjusted; lower lung function of 4.099 FEV 1 % predicted (95%CI 0.32 to 7.88 FEV 1 %) compared to patients without SCVs (Fig <ref type="figure" target="#fig_4">4</ref>).</s><s>Within a multivariable model also including antibiotic treatment, the association of SCVs with worse lung function was still significant (p = 0.0433, lower lung function in patients with SCVs of 3.89 FEV 1 % predicted, 95%CI 0.12 to 7.66 FEV 1 %).</s><s>In addition, patients with SCVs were more likely treated with trimethoprim/sulfamethoxazole (TMP/ SMX) compared to patients without SCVs (p = 0.0078).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-6 levels</head><p><s>Since interleukin-6 levels have been shown to be helpful as a potential marker for severity of inflammation <ref type="bibr" target="#b13">[14]</ref>, we determined IL-6 in sera of the study patients.</s><s>An inverse association between IL-6 levels and FEV 1 % predicted with worse lung function being associated with higher IL-6 at baseline (p&lt;0.001,</s><s><ref type="bibr">Fig 6)</ref>.</s><s>IL-6 levels were also associated with S. aureus density in sputa (p = 0.0016; difference of 0.6031 pg/ml in patients with high versus low S. aureus density), but not with bacterial density in throat or nasal cultures.</s><s>Moreover, a significant increase in IL-6 levels in patients with exacerbations (p = 0.0411; difference of 0.2104 pg/ml), SCVs (p = 0.0209; difference 0.2287 pg/ml), S. maltophilia (p = 0.0195; difference 0.2622 pg/ml) or with A. fumigatus (p = 0.0496; 0.2256 pg/ml) was documented.</s><s>In addition, significantly more CF patients with high bacterial loads displayed elevated IL-6 levels above the upper normal limit of 12 pg/ml <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24]</ref> compared to patients with sputa containing low bacterial loads (p = 0.0142).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Humoral response towards S. aureus</head><p><s>Recently, the height of S. aureus toxin-specific IgG-levels has been associated with the presence of S. aureus in airway specimens of CF patients, the severity of exacerbations and with FEV 1 % predicted <ref type="bibr" target="#b24">[25]</ref>.</s><s>To expand on these results, we measured IgG-levels against 44 different virulence factors of S. aureus (Supplemental Materials) in single serum samples of 182 CF patients and included the results in our analysis.</s><s>Furthermore, IgG-levels of patients were compared to those of 53 healthy adult volunteers with persistent nasal S. aureus carriage.</s><s>IgG-levels against 15 out of 44 analyzed antigens were significantly higher in patients compared to controls (p&lt;0.001,</s><s>Table <ref type="table" target="#tab_2">3</ref>).</s><s>It is noteworthy that, IgG-levels against 22 virulence factors were significantly and positively associated with IL-6 levels in all CF patients and, in line with previous data, IgG-levels against 18 virulence factors were significantly and inversely associated with FEV 1 % predicted (S2 Table <ref type="table">)</ref>.</s><s>A significant positive association between specific IgG-levels and nasal carriage, presence of SCVs and exacerbations for respectively 14, 16 and 7 antigens (S2 Table <ref type="table">)</ref> was reported.</s><s>Finally, no significant differences were found in IgG-levels of patients expectorating sputum with high and low bacterial loads (S2 Table <ref type="table">)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Using a generalized linear mixed model our data only seem to support our main hypothesis stating that S. aureus density has an impact on lung function for patients who provided throat swabs since we could show that patients with higher bacterial density in throat cultures experienced a steeper lung function decline compared to patients with low bacterial density in these airway specimens, Fig 1 <ref type="figure">.</ref></s><s>However, a closer look at our data showed that this effect was mostly carried by older patients, who provided throat cultures.</s><s>The effect was lost, if only the group of patients younger than 20 years was analyzed, which is why these results should be interpreted carefully.</s><s>Yet a trend of worse lung function of patients with high S. aureus density in sputa compared to patients with low S. aureus density was observed during the study period if cumulative clinical symptoms according to Fuchs were included in the linear mixed model analysis (p = 0.0661, S1 Fig).</s></p><p><s>With our inclusion and exclusion criteria a subgroup of patients was selected that differed from the German CF population by a preponderance of male patients (61.5%) and overrepresentation of non-p.Phe508del CFTR genotypes (27.7%).</s><s>The fact that our study patients experienced a mean lung function decline of -1.2717 FEV 1 % predicted per years of age are consistent with German registry data that carriers of non-F508del genotypes become later in life colonized with P. aeruginosa than F508del compound heterozygotes and homozygotes and experience a milder course of the disease <ref type="bibr" target="#b25">[26]</ref>.</s><s>Nevertheless, our study patients still fit into the general CF-population with a lung function decline of 1 to 3 FEV 1 % points per year as previously described <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b27">28]</ref> and do therefore not differ in terms of severity of the clinical disease.</s></p><p><s>Recently, in a retrospective single center study Ahlgren et al. compared CF patients, who were colonized with S. aureus or P. aeruginosa only, or neither of these pathogens <ref type="bibr" target="#b28">[29]</ref>.</s><s>In their study, which also included more male patients (n = 55%), 24% of 84 patients were colonized by S. aureus <ref type="bibr" target="#b28">[29]</ref>.</s><s>In conjunction with our data this may suggest that male patients are more likely colonized by S. aureus only and are more likely resistant to colonization or infection caused by P. aeruginosa.</s></p><p><s>Several studies have shown that persistent nasal S. aureus carriers are at increased risk for severe S. aureus infections, but have a survival advantage during sepsis <ref type="bibr" target="#b12">[13]</ref>.</s><s>We thus determined the impact of nasal S. aureus carriage in CF patients on disease progression.</s><s>Nasal carriage was higher than in other studies assessing nasal carriage as a risk factor for S. aureus infection <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref> both in healthy persons <ref type="bibr" target="#b31">[32]</ref> and in CF patients <ref type="bibr" target="#b10">[11]</ref>, but comparable to the study of Goerke et al. <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>This is most likely attributable to the pre-selection on the basis of our inclusion criteria with the requirement of S. aureus persistence in patients' airways.</s></p><p><s>During the study period the number of patients experiencing at least one pulmonary exacerbation was somewhat lower in our study compared to the study by Sanders et al. (31% versus 40%), who determined the association of frequency of exacerbations and subsequent lung function decline in more than 8.000 CF patients retrospectively <ref type="bibr" target="#b32">[33]</ref>.</s><s>This observation is most likely due to the fact that we excluded patients with chronic P. aeruginosa infection who have been shown to experience a more severe course of disease <ref type="bibr" target="#b33">[34]</ref>.</s></p><p><s>Our data thus clearly show that the culture of SCVs was independent of P. aeruginosa coinfection, but associated with advanced age, lower lung function and treatment with TMP/ SMX at both base line and during the study period.</s><s>Recently, Wolter et al. showed that the recovery of SCVs in airway specimens is independently associated with worse lung function in children <ref type="bibr" target="#b34">[35]</ref>.</s><s>Further studies also indicate that the detection of S. aureus SCVs was associated with persistence of S. aureus in airway specimens <ref type="bibr" target="#b18">[19]</ref>, advanced age <ref type="bibr" target="#b35">[36]</ref>, worse lung function <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref> and co-infection with P. aeruginosa <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s>However, in our study we ruled out any impact of P. aeruginosa by excluding patients with persistent P. aeruginosa infection.</s><s>In future analyses, it will be investigated if special geno-or phenotypes of S. aureus have an impact on the clinical status of the patients.</s></p><p><s>In our study, patients co-infected by S. maltophilia differed from patients without S. maltophilia.</s><s>They were most likely female, not S. aureus nasal carriers, co-infected with S. aureus SCVs and experienced more exacerbations.</s><s>While Goss et al. <ref type="bibr" target="#b37">[38]</ref> did not find any impact of S. maltophilia on lung function, Waters et al. have recently shown that S. maltophilia represented an independent risk factor for pulmonary exacerbations <ref type="bibr" target="#b38">[39]</ref>, when patients were persistently colonized with S. maltophilia.</s><s>Although we did not distinguish between S. maltophilia cultured once or persistently, co-infection by S. maltophilia clearly had a negative impact on the clinical status of our patients.</s></p><p><s>Also, patients co-infected by A. fumigatus significantly differed from patients without A. fumigatus with respect to age and prevalence of SCVs.</s><s>Surprisingly, patients with A. fumigatus exhibited a better lung function (data not shown) compared to patients without the fungus.</s><s>This is in contrast to the results reported by Amin et al. <ref type="bibr" target="#b39">[40]</ref> showing worse lung function for 37 out of 230 CF patients with persistent A. fumigatus infection.</s><s>This discrepancy may be due to the fact that we did not distinguish between intermittent and chronic infection.</s><s>It may also be explained by a sampling effect as we primarily cultured A. fumigatus from a small number of mostly A. fumigatus-positive older patients.</s></p><p><s>Recently, Horsley et al. documented IL-6 as a key biomarker of inflammation in CF patients with exacerbations <ref type="bibr" target="#b13">[14]</ref>.</s><s>We found that IL-6 levels were significantly correlated with S. aureus density in sputa, and with the presence of exacerbations, SCVs, S. maltophilia or A. fumigatus.</s><s>Thus, these results suggest that IL-6 is a highly sensitive marker for lung disease.</s><s>IL-6 may potentially be used to identify patients, which might benefit from initiation of antibiotic therapy.</s></p><p><s>CF patients mounted higher IgG-levels against numerous virulence factors of S. aureus compared to healthy controls.</s><s>Such an immune response against S. aureus is comparable to those of patients that exhibited S. aureus bacteremia or osteomyelitis <ref type="bibr" target="#b19">[20]</ref>.</s><s>The fact that the adaptive immune system produces specific antibodies against S. aureus underlines that persistently colonized CF patients are immunologically challenged by S. aureus although these specific antibodies cannot resolve S. aureus persistence.</s><s>While no significant association between  bacterial density in airway specimens of CF patients and IgG-levels was reported, we found a significant association of many specific IgG-values with IL-6-levels, worse lung function, nasal carriage and the culture of SCVs.</s><s>The latter confirms and expands on another recent study that demonstrated a significant inverse association between S. aureus toxin-specific IgG-levels and lung function in CF patients <ref type="bibr" target="#b24">[25]</ref>.</s><s>In contrast to our results, this previous study also showed a significant association between the culture of S. aureus in airway specimens and IgGlevels, albeit bacterial density was not quantified as it was done in our study.</s></p><p><s>There are several limitations to our study.</s><s>First, our inclusion and exclusion criteria selected a sub-group of CF patients, which do not reflect the entire CF population.</s><s>However, lung function data of our patients were comparable to other studies <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b40">41]</ref>.</s><s>Our data should thus provide meaningful results for the general CF population.</s><s>Second, our selected patient group did experience somewhat less exacerbations compared to groups with P. aeruginosa infection, which makes it more difficult to detect significant clinical differences between groups using exacerbation as an outcome measure.</s><s>Third, the technique of obtaining throat swabs in the different centres by different nurses or physicians could have influenced the microbiological results of the throat swab cultures.</s><s>Fourth, it seems that our study was underpowered to show significant results for the association between S. aureus density and worse lung function of patients, who were able to expectorate sputum.</s><s>Since S. aureus is the most prevalent CF-related pathogen in children, we included patients in our study who were not able to expectorate sputum.</s><s>We hypothesized that the determination of bacterial densities would be of equal value for throat swabs and sputa.</s><s>Our patient number calculation was based on this hypothesis.</s><s>However, there was no association between bacterial density and lung function for patients with throat swabs, but a trend for patients with high bacterial density in sputa if cumulative clinical symptoms for exacerbation were included in the analysis (0.0661, S1 Fig).</s></p><p><s>To conclude, our results suggest that the presence of exacerbations, non-nasal S. aureus carriage, female gender, the presence of S. aureus SCVs, co-infection with S. maltophilia or specific anti-staphylococcal IgG-and IL-6 levels are independent risk factors for worse lung function in CF patients with persistent S. aureus infection.</s><s>Our findings may help to identify S. aureus patients at risk for more severe airway infections resulting in worse lung function and will be of value for designing future prospective studies to guide antibiotic therapy in patients chronically infected with S. aureus.</s></p><p><s>during the study period and Marguerite Honer from the Mukoviszidose Institut, who assisted in patient recruitment.</s><s>Furthermore, we would like to thank all staff at the 17 centers for their patience and resolving difficulties with overnight shipment.</s><s>Lastly, we would like to thank the patients and parents of young patients who contributed to this study.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>doi:10.1371/journal.pone.0166220.t001</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Patients with throat cultures with high bacterial density experience a more rapid lung function decline.</s><s>Patients with high bacterial density in throat specimens are indicated by red squares, patients with low bacterial density in throat specimens by blue circles, the fitted model prediction is coloured accordingly.</s><s>doi:10.1371/journal.pone.0166220.g001</s></p></div></figDesc><graphic coords="8,95.98,78.01,479.91,360.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Patients with exacerbations have worse lung function.</s><s>Patients with exacerbation are indicated by red squares, patients without exacerbation by blue circles, the fitted model prediction is coloured accordingly.</s><s>doi:10.1371/journal.pone.0166220.g002</s></p></div></figDesc><graphic coords="9,95.98,78.01,479.91,360.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Patients with S. aureus nasal carriage have better lung function.</s><s>S. aureus nasal carriers are indicated by blue squares, nonnasal carriers by red circles, fitted model prediction is coloured accordingly.</s><s>doi:10.1371/journal.pone.0166220.g003</s></p></div></figDesc><graphic coords="10,95.98,78.01,479.91,360.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Patients with SCVs have worse lung function.</s><s>Patients with SCVs are indicated by red squares, patients without SCVs by blue circles, fitted model prediction is coloured accordingly.</s><s>doi:10.1371/journal.pone.0166220.g004</s></p></div></figDesc><graphic coords="11,200.01,78.01,359.94,270.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig 5 .</head><label>5</label><figDesc><div><p><s>Fig 5. Patients with culture of S. maltophilia have worse lung function.</s><s>Patients with S. maltophilia are indicated by red squares, patients without S. maltophilia by blue circles, fitted model prediction is coloured accordingly.</s><s>doi:10.1371/journal.pone.0166220.g005</s></p></div></figDesc><graphic coords="12,95.98,78.01,479.91,360.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig 6 .</head><label>6</label><figDesc><div><p><s>Fig 6.</s><s>Higher IL-6 is associated with lower FEV1% predicted.</s><s>Scatterplot of baseline measurements (n = 88) of all patients with blood samples provided at the first visit.</s><s>The fit line shows the results of a non-linear regression model.</s><s>Dark shaded areas show 95% confidence band, lighter shaded area shows 95% prediction band.</s><s>doi:10.1371/journal.pone.0166220.g006</s></p></div></figDesc><graphic coords="13,144.00,78.01,431.94,275.19" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>d p-values of correlation between IgG and IL-6 e adjusted p-values (Bonferroni correction) doi:10.1371/journal.pone.0166220.t003</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Characteristics of study patients compared to the German CF population. Study patients a German CF patients p-value</head><label>1</label><figDesc></figDesc><table><row><cell># of patients</cell><cell>195</cell><cell>4456</cell><cell></cell></row><row><cell>Age (in years)</cell><cell>16 (6-42)</cell><cell>20 (6-70)</cell><cell>&lt;0.001</cell></row><row><cell>Male</cell><cell>120 (61%)</cell><cell>2121 (48%)</cell><cell>&lt;0.001</cell></row><row><cell>Ex.panc.suff. b</cell><cell>22 (11%)</cell><cell>1426 (32%)</cell><cell>&lt;0.001</cell></row><row><cell>FEV 1 (% predicted)</cell><cell>84.1 (13-121)</cell><cell>72.0 (10-145)</cell><cell>&lt;0.001</cell></row><row><cell>BMI-quantils</cell><cell>25% (0.07-100%)</cell><cell>27% (0.05-100%)</cell><cell>0.007</cell></row><row><cell>Genotype c</cell><cell>173</cell><cell>3832</cell><cell></cell></row><row><cell>F508del homo d</cell><cell>85 (49%)</cell><cell>1863 (49%)</cell><cell>&lt;0.001</cell></row><row><cell>F508del hetero e</cell><cell>40 (23%)</cell><cell>1429 (37%)</cell><cell></cell></row><row><cell>others</cell><cell>48 (28%)</cell><cell>540 (14%)</cell><cell></cell></row></table><note><p><s>a</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 . Positive airway specimens according to S. aureus density. Specimens Low density (&lt;1x10 6 CFU/ml) score 1, 2 a (%) High density (&gt;/ = 1x10 6 CFU/ml) score 3 b (%) Sum</head><label>2</label><figDesc></figDesc><table><row><cell>Nasal swabs</cell><cell>517 (68.7)</cell><cell>236 (31.3)</cell><cell>753</cell></row><row><cell>Nasal lavage</cell><cell>26 (76.5)</cell><cell>8 (23.5)</cell><cell>34</cell></row><row><cell>Throat swabs</cell><cell>545 (69.7)</cell><cell>237 (30.3)</cell><cell>782</cell></row><row><cell>Sputa</cell><cell>166 (42.1)</cell><cell>228 (57.9)</cell><cell>394</cell></row><row><cell>All</cell><cell>1254 (63.9)</cell><cell>709 (36.1)</cell><cell>1963</cell></row><row><cell cols="2">a low bacterial density of sputum (&lt;1x10 6 CFU/ml) and throat cultures (score 1 and 2)</cell><cell></cell><cell></cell></row><row><cell cols="2">b high bacterial density of sputum (!1x10 6 CFU/ml) and throat cultures (score !3)</cell><cell></cell><cell></cell></row><row><cell>doi:10.1371/journal.pone.0166220.t002</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 . Significant specific IgG levels against S. aureus antigens in CF patients compared to healthy controls. Antigen Mean IgG level patients (± SE) a Mean IgG level controls (± SE) a p value b,e Correlation coefficient of IgG and IL-6 levels c p value d</head><label>3</label><figDesc><div><p><s>Spearman's rank correlation coefficients were calculated for IgG-and IL-6 levels in all patients.</s></p></div></figDesc><table><row><cell>Efb</cell><cell>4605 (±210)</cell><cell>2089 (±208)</cell><cell>&lt; 0.0001</cell><cell>0.010</cell><cell>0.840</cell></row><row><cell cols="2">Glucosaminidase 14992 (±250)</cell><cell>11567 (±571)</cell><cell>&lt; 0.0001</cell><cell>0.147</cell><cell>0.002</cell></row><row><cell>HlgB</cell><cell>13621 (±174)</cell><cell>9878 (±407)</cell><cell>&lt; 0.0001</cell><cell>0.061</cell><cell>0.197</cell></row><row><cell>IsaA</cell><cell>13288 (±413)</cell><cell>10479 (±678)</cell><cell>0.0009</cell><cell>0.207</cell><cell>&lt; 0.0001</cell></row><row><cell>IsdA</cell><cell>10701 (±250)</cell><cell>7638 (±429)</cell><cell>&lt; 0.0001</cell><cell>0.304</cell><cell>&lt; 0.0001</cell></row><row><cell>LukD</cell><cell>14176 (±248)</cell><cell>11485 (±464)</cell><cell>&lt; 0.0001</cell><cell>0.14</cell><cell>0.003</cell></row><row><cell>LukE</cell><cell>14272 (±238)</cell><cell>11720 (±474)</cell><cell>&lt; 0.0001</cell><cell>0.169</cell><cell>&lt; 0.0001</cell></row><row><cell>LukF</cell><cell>4079 (±121)</cell><cell>2718 (±243)</cell><cell>&lt; 0.0001</cell><cell>0.169</cell><cell>&lt; 0.0001</cell></row><row><cell>LukS</cell><cell>14097 (±239)</cell><cell>7134 (±524)</cell><cell>&lt; 0.0001</cell><cell>0.206</cell><cell>&lt; 0.0001</cell></row><row><cell>LytM</cell><cell>6576 (±308)</cell><cell>3555 (±380)</cell><cell>0.0001</cell><cell>0.27</cell><cell>&lt; 0.0001</cell></row><row><cell>Nuc</cell><cell>14405 (±271)</cell><cell>4752 (±493)</cell><cell>&lt; 0.0001</cell><cell>0.0837</cell><cell>0.0795</cell></row><row><cell>SA0688</cell><cell>3063 (±259)</cell><cell>760 (±116)</cell><cell>&lt; 0.0001</cell><cell>0.355</cell><cell>&lt; 0.0001</cell></row><row><cell>SSL5</cell><cell>2589 (±128)</cell><cell>1616 (±111)</cell><cell>&lt; 0.0001</cell><cell>-0.020</cell><cell>0.669</cell></row><row><cell>SSL9</cell><cell>8910 (±194)</cell><cell>7568 (±306)</cell><cell>0.0009</cell><cell>0.079</cell><cell>0.098</cell></row><row><cell cols="2">Wall teichoic acid 2491 (±124)</cell><cell>319 (±117)</cell><cell>&lt; 0.0001</cell><cell>0.109</cell><cell>0.025</cell></row></table><note><p><s>a Average IgG levels are given in mean fluorescence activity (MFI).</s><s>b p-values of difference between 190 patients and 53 healthy controls (Mann-Whitney U test) c</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0166220November 18, 2016  </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We are grateful to the work of B. Gru ¨nastel, who contributed to the organization and set-up of the study, D. Kaiser who performed all microbiological work-up and organization of data</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><note type="other">S1</note></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cystic fibrosis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>O'sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Freedman</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(09)60327-5</idno>
		<idno type="PMID">19403164</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="60327" to="60332" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Zolin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Mckone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Rens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Iansa</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2016. 2013</date>
		</imprint>
	</monogr>
	<note type="report_type">ECFSPR Annual Report</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Saiman</surname></persName>
		</author>
		<idno type="DOI">10.1097/MCP.0b013e3282efbbac</idno>
		<idno type="PMID">17901758</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Pulm Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="515" to="521" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Annual Data Report. Cystic Fibrosis Foundation Patient Registry</title>
	</analytic>
	<monogr>
		<title level="m">Cystic Fibrosis Foundation</title>
				<meeting><address><addrLine>Bethesda, Maryland</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2014">2015. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gangell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Keil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ranganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Robins-Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Sly</surname></persName>
		</author>
		<idno type="DOI">10.1093/cid/cir399</idno>
		<idno type="PMID">21844026</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="425" to="432" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Sagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Emerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcnamara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Wagener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Ramsey</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpeds.2008.08.001</idno>
		<idno type="PMID">18822427</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="183" to="188" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Prophylactic anti-staphylococcal antibiotics for cystic fibrosis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Smyth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Walters</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.CD001912.pub2</idno>
		<idno type="PMID">23235585</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">D001912</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ranganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Skoric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Robins-Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>De Klerk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Sly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Stick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hall</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201407-1277OC</idno>
		<idno type="PMID">25321321</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="1111" to="1116" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Staphylococcus aureus in early cystic fibrosis lung disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Ranganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hart</surname></persName>
		</author>
		<idno type="DOI">10.1002/ppul.22863</idno>
		<idno type="PMID">23970476</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatr Pulmonol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1151" to="1159" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The role of nasal carriage in Staphylococcus aureus infections</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Wertheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Melles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Verbrugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Nouwen</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1473-3099(05)70295-4</idno>
		<idno type="PMID">16310147</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Infect Dis</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="751" to="762" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ridder-Schaphorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ratjen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dubbers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Haberle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Mellies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reintjes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Kahl</surname></persName>
		</author>
		<idno type="DOI">10.1128/JCM.00855-07</idno>
		<idno type="PMID">17652474</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="2979" to="2984" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients</title>
		<author>
			<persName><forename type="first">C</forename><surname>Goerke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kraning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Doring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Botzenhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wolz</surname></persName>
		</author>
		<idno type="DOI">10.1086/315331</idno>
		<idno type="PMID">10720521</idno>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="page" from="984" to="989" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Wertheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Voss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kluytmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Van Keulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Vandenbroucke-Grauls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Meester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Verbrugh</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(04)16897-9</idno>
		<idno type="PMID">15325835</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page" from="703" to="705" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Horsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Macleod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Donovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Aziz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mt-Isa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Voase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Dewar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Parra-Leiton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jeswiet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Soussi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bakar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Meister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Doherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Hansell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ashby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hyde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Greening</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Porteous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Innes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Boyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Griesenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alton</forename><forename type="middle">Ew</forename></persName>
		</author>
		<idno type="DOI">10.1136/thoraxjnl-2012-202538</idno>
		<idno type="PMID">23396354</idno>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="532" to="539" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mensa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trilla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="42" to="54" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Borowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Nash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Rosenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wohl</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199409083311003</idno>
		<idno type="PMID">7503821</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="637" to="642" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Atemwegsinfektionen bei Mukoviszidose (airway infections in cystic fibrosis)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hogardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ha ¨ußler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Balke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Kahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schmoldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leitritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kappler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Suerbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Heesemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mu ¨nchen</title>
		<imprint>
			<date type="published" when="2006">2006</date>
			<publisher>Elsevier</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Assessment of Microbiological Diagnostic Procedures for Respiratory Specimens from Cystic Fibrosis Patients in German Laboratories by a Questionnaire</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hafner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Kahl</surname></persName>
		</author>
		<idno type="DOI">10.1128/JCM.02866-13</idno>
		<idno type="PMID">24391197</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="977" to="979" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Kahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Everding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Harms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Proctor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Peters</surname></persName>
		</author>
		<idno type="PMID">9534977</idno>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="1023" to="1029" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Den Reijer</surname></persName>
		</author>
		<author>
			<persName><surname>Lemmens-Den</surname></persName>
		</author>
		<author>
			<persName><surname>Tn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Snijders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Boelens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tavakol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Verkaik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Verbrugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Van Wamel</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0053391</idno>
		<idno type="PMID">23308212</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e53391</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Verkaik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Boelens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hoogenboezem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hooijkaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Verbrugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Ba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Van Wamel</surname></persName>
		</author>
		<idno type="DOI">10.1086/596743</idno>
		<idno type="PMID">19199541</idno>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="page" from="625" to="632" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Quanjer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stanojevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Baur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Culver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Enright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hankinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Ip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stocks</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00080312</idno>
		<idno type="PMID">22743675</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1324" to="1343" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fwity</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lobmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ambrosch</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1751-553X.2009.01202.x</idno>
		<idno type="PMID">19919621</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Lab Hematol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="410" to="418" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gaini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">G</forename><surname>Koldkjaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Pedersen</surname></persName>
		</author>
		<idno type="DOI">10.1186/cc4866</idno>
		<idno type="PMID">16569262</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">R53</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Chadha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">P</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jimenez-Truque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Soper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Sokolow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Creech</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jcf.2015.12.023</idno>
		<idno type="PMID">26821814</idno>
	</analytic>
	<monogr>
		<title level="j">J Cyst Fibros</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="597" to="604" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Mckone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Emerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Aitken</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(03)13368-5</idno>
		<idno type="PMID">12767731</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="1671" to="1676" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kerem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Viviani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zolin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macneill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hatziagorou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ellemunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Drevinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gulmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Krivec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Olesen</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00166412</idno>
		<idno type="PMID">23598952</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="125" to="133" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Year-to-year changes in lung function in individuals with cystic fibrosis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Liou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Elkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Pasta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Konstan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Wagener</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jcf.2010.04.002</idno>
		<idno type="PMID">20471331</idno>
	</analytic>
	<monogr>
		<title level="j">J Cyst Fibros</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="250" to="256" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Ahlgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Benedetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Landry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bernier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Matouk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Radzioch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Lands</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rousseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nguyen</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12890-015-0062-7</idno>
		<idno type="PMID">26093634</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Pulm Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">67</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Luzar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Coles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Faller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Slingeneyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Dah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Briat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Knefati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Peluso</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199002223220804</idno>
		<idno type="PMID">2300122</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="505" to="509" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Preoperative risk factors for nasal carriage of Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Herwaldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Cullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pfaller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Perl</surname></persName>
		</author>
		<idno type="DOI">10.1086/502426</idno>
		<idno type="PMID">15242196</idno>
	</analytic>
	<monogr>
		<title level="j">Infect Control Hosp Epidemiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="481" to="484" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Eriksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Espersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">T</forename><surname>Rosdahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jensen</surname></persName>
		</author>
		<idno type="PMID">7641838</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiol Infect</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="51" to="60" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Bittner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Redding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Goss</surname></persName>
		</author>
		<idno type="DOI">10.1002/ppul.21374</idno>
		<idno type="PMID">20967845</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatr Pulmonol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="393" to="400" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Kosorok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Laxova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Splaingard</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.293.5.581</idno>
		<idno type="PMID">15687313</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="581" to="588" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Wolter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Emerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcnamara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Buccat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cochrane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Houston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Marsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Prehar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Pope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Blackledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Deziel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Bruce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Hoffman</surname></persName>
		</author>
		<idno type="DOI">10.1093/cid/cit270</idno>
		<idno type="PMID">23625938</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="page" from="384" to="391" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Besier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Smaczny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Mc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ackermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Brade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Wichelhaus</surname></persName>
		</author>
		<idno type="DOI">10.1128/JCM.01510-06</idno>
		<idno type="PMID">17108072</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="168" to="172" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Muhlemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Droz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Couzinet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Casaulta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zimmerli</surname></persName>
		</author>
		<idno type="DOI">10.1128/JCM.00361-08</idno>
		<idno type="PMID">18322058</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1832" to="1834" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Goss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mayer-Hamblett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Aitken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Rubenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Ramsey</surname></persName>
		</author>
		<idno type="DOI">10.1136/thx.2003.017707</idno>
		<idno type="PMID">15516471</idno>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="955" to="959" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Waters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Atenafu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Crandall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tullis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ratjen</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201009-1392OC</idno>
		<idno type="PMID">20889901</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="635" to="640" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Amin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dupuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Aaron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ratjen</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.09-1103</idno>
		<idno type="PMID">19567494</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="171" to="176" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Risk factors for lung function decline in a large cohort of young cystic fibrosis patients</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cogen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Emerson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Schechter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosenfeld</surname></persName>
		</author>
		<idno type="DOI">10.1002/ppul.23217</idno>
		<idno type="PMID">26061914</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatr Pulmonol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="763" to="770" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
